Core Points - N Jinhua (920015) was listed on the Beijing Stock Exchange, opening with a significant increase of 114.88% and closing with a total gain of 133.00% [2] - The company specializes in the research, production, and sales of ketoxime series fine chemicals [2] Financial Performance - The net profits for the company are projected to be 79.59 million yuan in 2022, 173 million yuan in 2023, and 211 million yuan in 2024 [3] - The public offering consisted of 32.67 million shares at an issuance price of 18.15 yuan, resulting in a price-to-earnings ratio of 11.52 [3] Issuance Details - The online issuance volume was initially 26.13 million shares, which was increased to 31.03 million shares due to an oversubscription mechanism [3] - The effective subscription amount for the online issuance reached 46,897,366.69 million shares, with a subscription multiple of 1511.19 times and a distribution ratio of 0.07% [3] Market Performance - The trading volume for N Jinhua on its first day was 28.31 million shares, with a total transaction value of 1.132 billion yuan and a turnover rate of 91.23% [2] - A comparison of recent IPOs shows that N Jinhua's first-day closing price of 42.29 yuan represents a 133.00% increase from its issuance price [3][4]
N锦华收盘上涨133.00% 首日换手率91.23%